Literature DB >> 3546398

Diversity of autoantibodies in patients with antimitochondrial antibody and their diagnostic value.

S A McMillan, J M Alderdice, C M McKee, A T Dawson, M E Callender, T T Fulton, M Haire.   

Abstract

A retrospective analysis of clinical and laboratory features of 102 patients, whose sera contained antibody to mitochondria, showed that primary biliary cirrhosis was diagnosed in 50% of them. Immunofluorescence showed that the sera of the patients with primary biliary cirrhosis all had the M2 antimitochondrial antibody staining pattern. A new staining pattern, designated M2(1), which could be mistaken for the M2 pattern, was not found in any patients with either primary biliary cirrhosis or chronic active hepatitis. Other serological variables such as antibody to mitochondria in IgM class, to multiple nuclear dots, and to the XR antigen, were associated with primary biliary cirrhosis, and taken in association with antimitochondrial antibody of M2 type, contribute to the diagnosis of the disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3546398      PMCID: PMC1140874          DOI: 10.1136/jcp.40.2.232

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  A new pattern of non-organ- and non-species-specific anti-organelle antibody detected by immunofluorescence: the mitochondrial antibody number 5.

Authors:  M T Labro; M C Andrieu; M Weber; J C Homberg
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

2.  Mitochondrial antibody in primary biliary cirrhosis and other diseases.

Authors:  G Klatskin; F S Kantor
Journal:  Ann Intern Med       Date:  1972-10       Impact factor: 25.391

3.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

Review 4.  The complex nature of mitochondrial antibodies and their relation to primary biliary cirrhosis.

Authors:  H Baum; P A Berg
Journal:  Semin Liver Dis       Date:  1981-11       Impact factor: 6.115

5.  Purification of an acidic nuclear protein antigen and demonstration of its antibodies in subsets of patients with sicca syndrome.

Authors:  M Akizuki; M J Boehm-Truitt; S S Kassan; A D Steinberg; T M Chused
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

Review 6.  Clinical and prognostic relevance of different mitochondrial antibody profiles in primary biliary cirrhosis (PBC).

Authors:  P A Berg; R Klein
Journal:  Mol Aspects Med       Date:  1985

7.  Antibodies to cellular antigens in Sjögren's syndrome.

Authors:  M A Alspaugh; E M Tan
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

8.  What does the antimitochondrial antibody mean?

Authors:  D R Triger; C A Charlton; A M Ward
Journal:  Gut       Date:  1982-10       Impact factor: 23.059

9.  Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis.

Authors:  C C Bunn; A E Gharavi; G R Hughes
Journal:  J Clin Lab Immunol       Date:  1982-05

10.  Is mitochondrial antibody diagnostic of primary biliary cirrhosis?

Authors:  L E Munoz; H C Thomas; P J Scheuer; D Doniach; S Sherlock
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

View more
  3 in total

1.  Prognostic importance of nucleolar organiser regions in embryonal rhabdomyosarcoma.

Authors:  M J Egan; F Raafat; J Crocker; D Williams
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

2.  A new fluorescent mitochondrial antibody: disease association.

Authors:  N A Boyd; S A McMillan; A C Fay
Journal:  Ir J Med Sci       Date:  1989-09       Impact factor: 1.568

3.  The cytoplasmic linker protein CLIP-170 is a human autoantigen.

Authors:  K J Griffith; J P Ryan; J-L Senécal; M J Fritzler
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.